182 related articles for article (PubMed ID: 38692297)
1. CAR T-Cell Therapy in Autoimmune Disease.
Merkt W; Lorenz HM; Schmitt M
N Engl J Med; 2024 May; 390(17):1628-1629. PubMed ID: 38692297
[No Abstract] [Full Text] [Related]
2. CAR T-Cell Therapy in Autoimmune Disease.
Howard JF; Vu T; Mozaffar T
N Engl J Med; 2024 May; 390(17):1629-1631. PubMed ID: 38692299
[No Abstract] [Full Text] [Related]
3. CAR T-Cell Therapy in Autoimmune Disease.
De Benedetti F; Diomedi Camassei F; Locatelli F
N Engl J Med; 2024 May; 390(17):1629. PubMed ID: 38692298
[No Abstract] [Full Text] [Related]
4. CAR T-Cell Therapy in Autoimmune Disease. Reply.
Müller F; Mackensen A; Schett G
N Engl J Med; 2024 May; 390(17):1631-1632. PubMed ID: 38692300
[No Abstract] [Full Text] [Related]
5. Chimeric antigen receptor T cell therapy: a new emerging landscape in autoimmune rheumatic diseases.
Lyu X; Gupta L; Tholouli E; Chinoy H
Rheumatology (Oxford); 2024 May; 63(5):1206-1216. PubMed ID: 37982747
[TBL] [Abstract][Full Text] [Related]
6. Dawn of CAR-T cell therapy in autoimmune diseases.
Liu Y; Dong M; Chu Y; Zhou L; You Y; Pang X; Yang S; Zhang L; Chen L; Zhu L; Xiao J; Wang W; Qin C; Tian D
Chin Med J (Engl); 2024 May; 137(10):1140-1150. PubMed ID: 38613216
[TBL] [Abstract][Full Text] [Related]
7. CAR T-cell therapy in autoimmune diseases.
Schett G; Mackensen A; Mougiakakos D
Lancet; 2023 Nov; 402(10416):2034-2044. PubMed ID: 37748491
[TBL] [Abstract][Full Text] [Related]
8. Is There a Place for Chimeric Antigen Receptor-T Cells in the Treatment of Chronic Autoimmune Rheumatic Diseases?
Orvain C; Boulch M; Bousso P; Allanore Y; Avouac J
Arthritis Rheumatol; 2021 Nov; 73(11):1954-1965. PubMed ID: 34042325
[TBL] [Abstract][Full Text] [Related]
9. CAR T cells for infection, autoimmunity and allotransplantation.
Maldini CR; Ellis GI; Riley JL
Nat Rev Immunol; 2018 Oct; 18(10):605-616. PubMed ID: 30046149
[TBL] [Abstract][Full Text] [Related]
10. Prospects for CAR T cell immunotherapy in autoimmune diseases: clues from Lupus.
Radic M; Neeli I; Marion T
Expert Opin Biol Ther; 2022 Apr; 22(4):499-507. PubMed ID: 35089116
[TBL] [Abstract][Full Text] [Related]
11. CAR-T cell therapy in systemic lupus erythematosus and beyond: a brave new world?
van Leuven SI; Duivenvoorden R
Rheumatology (Oxford); 2024 May; 63(5):1192-1194. PubMed ID: 38377390
[No Abstract] [Full Text] [Related]
12. Chimeric antigen receptor T-cell therapy beyond cancer: current practice and future prospects.
Zhang PF; Xie D; Li Q
Immunotherapy; 2020 Sep; 12(13):1021-1034. PubMed ID: 32727249
[TBL] [Abstract][Full Text] [Related]
13. CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus.
Mougiakakos D; Krönke G; Völkl S; Kretschmann S; Aigner M; Kharboutli S; Böltz S; Manger B; Mackensen A; Schett G
N Engl J Med; 2021 Aug; 385(6):567-569. PubMed ID: 34347960
[No Abstract] [Full Text] [Related]
14. Potential and pitfalls of repurposing the CAR-T cell regimen for the treatment of autoimmune disease.
Daamen AR; Lipsky PE
Ann Rheum Dis; 2024 May; 83(6):696-699. PubMed ID: 38637134
[TBL] [Abstract][Full Text] [Related]
15. Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma.
Chow VA; Shadman M; Gopal AK
Blood; 2018 Aug; 132(8):777-781. PubMed ID: 29914976
[TBL] [Abstract][Full Text] [Related]
16. Chimeric antigen receptor modified T cell therapy in B cell non-Hodgkin lymphomas.
Levin A; Shah NN
Am J Hematol; 2019 May; 94(S1):S18-S23. PubMed ID: 30652353
[TBL] [Abstract][Full Text] [Related]
17. Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus.
Kansal R; Richardson N; Neeli I; Khawaja S; Chamberlain D; Ghani M; Ghani QU; Balazs L; Beranova-Giorgianni S; Giorgianni F; Kochenderfer JN; Marion T; Albritton LM; Radic M
Sci Transl Med; 2019 Mar; 11(482):. PubMed ID: 30842314
[TBL] [Abstract][Full Text] [Related]
18. Beyond CD19 CAR-T cells in lymphoma.
Leung WK; Ayanambakkam A; Heslop HE; Hill LC
Curr Opin Immunol; 2022 Feb; 74():46-52. PubMed ID: 34800921
[TBL] [Abstract][Full Text] [Related]
19. Chimeric Antigen Receptor T Cell Therapy for Pediatric B-ALL: Narrowing the Gap Between Early and Long-Term Outcomes.
Schultz L
Front Immunol; 2020; 11():1985. PubMed ID: 32849662
[TBL] [Abstract][Full Text] [Related]
20. Safer CAR T-Cell Therapy.
Abbasi J
JAMA; 2019 Jun; 321(22):2155. PubMed ID: 31184718
[No Abstract] [Full Text] [Related]
[Next] [New Search]